HomeUncategorizedBioNTech begins clinical trial of mRNA-based malaria vaccine candidate

BioNTech begins clinical trial of mRNA-based malaria vaccine candidate

UncategorizedDecember 25, 2022
1 min read

Related Articles

TechnologyTangle
2026Jan 07

Building materials are getting closer to doubling as batteries

Concrete already builds our world, and an MIT-invented variant known as electron-­conducting carbon concrete (ec3, pronounced “e c cubed”) holds out the possibility of helping power it, too. Now that ...

Article2 min read
Read More